SZIHF yields 8.52% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, SZIHF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SZIHF + PFE for your $10,000?
Shenzhen International Holdings Limited, an investment holding company, invests in, constructs, and operates logistic infrastructure facilities primarily in the People's Republic of China. It operates through two segments, Toll roads and General Environmental Protection Business, and Logistic Business. The Toll roads and General Environmental Protection Business segment develops, operates, and manages toll highways. This segment also engages in the sale of wind turbine equipment; kitchen waste disposal projects construction; and operation and sale of wind power stations. The company's Logistic Business segment constructs, operates, and manages logistics parks and centers, and integrated logistics hubs; and provides third-party logistics services, logistic information services, and financial services; port and related services; and logistic park transformation and upgrading services. It also operates two general bulk cargo terminals and depots in Nanjing Xiba Port that provides various services, such as loading and unloading, lightering, train loading and unloading, and warehousing. In addition, the company provides electronic information exchange, transmission, and value-added information sharing services; supply chain management services; project investment and enterprise management consulting services; and real estate development and investment management services, as well as operates Longda and Shenzhen Expressway in Shenzhen. Further, it offers logistics and transportation ancillary services, and cargo transportation and warehousing services. Additionally, it provides technical development, sales, maintenance, and technology service of computer hardware, software, and network systems; and monetary and financial leasing, property leasing and management, freight forwarding, and other services. The company is headquartered in Tsimshatsui East, Hong Kong.
Full SZIHF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.